Skip to main content
. 2018 Mar 24;27(6):1024–1040. doi: 10.1002/hec.3654

Figure 2.

Figure 2

Proportion of trial participants with complete data for the primary cost‐effectiveness analysis. Shown for cost‐effectiveness (n = 52), effectiveness (n = 47, unclear in 5 studies), and cost data (n = 40, unclear in 12 studies)